| Literature DB >> 31662789 |
Xiuzhi Yang1,2,3, Yu Wu4, Jiqing Li1,2, Wuliang Yin5, Yang An1,2, Yanfen Wang1,2, Man Wang1,2, Qiuli Wu4, Zhigang Qu1,2, Guangzhi Ning4, Shiqing Feng4.
Abstract
To investigate how a back propagation neural network based on genetic algorithm (GA-BPNN) optimizes the low-intensity pulsed ultrasound (LIPUS) stimulation parameters to improve the bone marrow mesenchymal stem cells (BMSCs) viability further. The LIPUS parameters were set at various frequencies (0.6, 0.8, 1.0, and 1.2 MHz), voltages (5, 6, 7, and 8 V), and stimulation durations (3, 6, and 9 minutes). As only some discrete points can be set up in the experiments, the optimal LIPUS stimulation parameter may not be in the value of these settings. The GA-BPNN algorithm is used to optimize parameters of LIPUS to increase the BMSCs viability further. The BMSCs viability of the LIPUS-treated group was improved up to 19.57% (P < 0.01). With the optimization via the GA-BPNN algorithm, the viability of BMSCs was further improved by about 5.36% (P < 0.01) under the optimized condition of 6.92 V, 1.02 MHz, and 7.3 min. LIPUS is able to improve the BMSCs viability, which can be improved further by LIPUS with parameter optimization via GA-BPNN algorithm.Entities:
Mesh:
Year: 2019 PMID: 31662789 PMCID: PMC6791242 DOI: 10.1155/2019/8386024
Source DB: PubMed Journal: Comput Math Methods Med ISSN: 1748-670X Impact factor: 2.238
Figure 1The LIPUS experimental equipment.
Acoustic intensity (mW·cm−2) stimulates BMSCs at 5 mm.
| Voltage (V) | Frequency (MHz) | |||
|---|---|---|---|---|
| 0.6 | 0.8 | 1 | 1.2 | |
| 5 | 13.9 | 3.4 | 33.7 | 3.7 |
| 6 | 19.3 | 4.7 | 48.2 | 5.1 |
| 7 | 28.9 | 6.8 | 53.9 | 8 |
| 8 | 37.3 | 8.5 | 69.3 | 10 |
Figure 2Structure diagram of the three-layer BPNN model.
Figure 3Flow chart of the GA-BPNN algorithm.
Figure 4BMSCs proliferation with different parameters (n = 20). (a) BMSCs proliferation in the control group. (b) BMSCs proliferation with 3 min LIPUS stimulation. (c) BMSCs proliferation with 6 min LIPUS stimulation. (d) BMSCs proliferation with 9 min LIPUS stimulation (bar = 200 μm).
Figure 5The BMSCs viability (%) after LIPUS stimulation with different parameters (voltage, frequency, and stimulation duration). n = 5 for each group. LIPUS-treated group (0.6, 0.8, 1, and 1.2 MHz) versus control group (0 MHz), one-way ANOVA, P < 0.05, P < 0.01. (a) The BMSCs viability varied with frequency and voltage when the stimulation duration was 3 min. (b) The BMSCs viability varied with frequency and voltage when the stimulation duration was 6 min. (c) The BMSCs viability varied with frequency and voltage when the stimulation duration was 9 min.
BMSCs viability (%) after LIPUS stimulation with 3 min.
| Voltage (V) | Frequency (MHz) | ||||
|---|---|---|---|---|---|
| 0 | 0.6 | 0.8 | 1 | 1.2 | |
| 5 | 100 | 100.57 ± 6.52 | 103.40 ± 5.91 | 105.17 ± 7.17 | 100.92 ± 8.18 |
| Confidence intervals (%) | [100,100] | [97.52,103.62] | [100.63,106.16] | [101.81,108.53] | [97.09,104.74] |
|
| — | 0.699 | 0.014 | 0.003 | 0.619 |
|
| |||||
| 6 | 100 | 101.15 ± 16.08 | 104.81 ± 12.95 | 107.72 ± 14.07 | 100.71 ± 13.13 |
| Confidence intervals (%) | [100,100] | [93.62,108.68] | [98.75,110.87] | [101.13,114.30] | [94.57,106.86] |
|
| — | 0.751 | 0.105 | 0.019 | 0.81 |
|
| |||||
| 7 | 100 | 102.8 ± 10.92 | 102.84 ± 10.81 | 103.94 ± 6.54 | 100.59 ± 7.15 |
| Confidence intervals (%) | [100,100] | [97.69,107.91] | [97.78,107.90] | [100.88,106.10] | [97.24,103.94] |
|
| — | 0.259 | 0.248 | 0.01 | 0.715 |
|
| |||||
| 8 | 100 | 101.57 ± 7.73 | 102.46 ± 10.56 | 102.34 ± 12.14 | 101.48 ± 9.82 |
| Confidence intervals (%) | [100,100] | [97.95,105.20] | [97.51,107.40] | [96.66,108.02] | [96.88,106.07] |
|
| — | 0.368 | 0.305 | 0.394 | 0.505 |
Data presented as mean ± SD, n = 20 (P < 0.05, P < 0.01).
BMSCs viability (%) after LIPUS stimulation with 6 min.
| Voltage (V) | Frequency (MHz) | ||||
|---|---|---|---|---|---|
| 0 | 0.6 | 0.8 | 1 | 1.2 | |
| 5 | 100 | 105.89 ± 10.51 | 111.86 ± 6.87 | 111.91 ± 6.09 | 101.8 ± 9.8 |
| Confidence intervals (%) | [100,100] | [100.97,110.81] | [108.64,115.07] | [109.06,114.76] | [97.21,106.38] |
|
| — | 0.017 | 2.64 | 1.22 | 0.418 |
|
| |||||
| 6 | 100 | 105.94 ± 14.42 | 114.28 ± 7.7 | 114.45 ± 7.28 | 101.75 ± 9.43 |
| Confidence intervals (%) | [100,100] | [99.19,112.69] | [110.68,117.89] | [111.04,117.86] | [97.33,106.16] |
|
| — | 0.073 | 4.70 | 8.56 | 0.412 |
|
| |||||
| 7 | 100 | 109.02 ± 10.41 | 114.06 ± 7.33 | 114.64 ± 6.6 | 101.73 ± 10.3 |
| Confidence intervals (%) | [100,100] | [104.15,113.90] | [110.63,117.49] | [111.55,117.73] | [96.91,106.55] |
|
| — | 0.0004 | 1.99 | 4.24 | 0.458 |
|
| |||||
| 8 | 100 | 104.79 ± 16.66 | 107.28 ± 18.14 | 106.86 ± 20.24 | 102.77 ± 16.21 |
| Confidence intervals (%) | [100,100] | [96.99,112.58] | [98.79,115.77] | [97.38,116.33] | [95.18,110.35] |
|
| — | 0.206 | 0.081 | 0.138 | 0.45 |
Data presented as mean ± SD, n = 20 (P < 0.05, P < 0.01).
BMSCs viability (%) after LIPUS stimulation with 9 min.
| Voltage (V) | Frequency (MHz) | ||||
|---|---|---|---|---|---|
| 0 | 0.6 | 0.8 | 1 | 1.2 | |
| 5 | 100 | 107.64 ± 8.97 | 112.64 ± 3.53 | 114.33 ± 2.74 | 102.18 ± 6.7 |
| Confidence intervals (%) | [100,100] | [103.44,111.84] | [110.99,114.29] | [113.04,115.61] | [99.05,105.32] |
|
| — | 0.0005 | 1.66 | 3.90 | 0.153 |
|
| |||||
| 6 | 100 | 106.63 ± 12.5 | 118.55 ± 5.75 | 119.57 ± 3.85 | 100.67 ± 10.46 |
| Confidence intervals (%) | [100,100] | [100.78,112.49] | [115.87,121.24] | [117.77,121.37] | [95.77,105.56] |
|
| — | 0.023 | 5.15 | 1.00 | 0.777 |
|
| |||||
| 7 | 100 | 108.78 ± 9.49 | 116.21 ± 6.41 | 116.61 ± 7.49 | 102.36 ± 9.62 |
| Confidence intervals (%) | [100,100] | [104.34,113.22] | [113.21,119.21] | [113.10,120.11] | [97.85,106.86] |
|
| — | 0.0002 | 9.86 | 4.28 | 0.28 |
|
| |||||
| 8 | 100 | 103.17 ± 13.78 | 106.05 ± 14.84 | 105.95 ± 14.88 | 101.17 ± 10.47 |
| Confidence intervals (%) | [100,100] | [96.72,109.62] | [99.10,112.10] | [98.99,112.91] | [96.27,106.07] |
|
| — | 0.31 | 0.076 | 0.082 | 0.62 |
Data presented as mean ± SD, n = 20 (P < 0.05, P < 0.01).
Figure 6(a) The BMSCs viability with 3 min stimulation duration. (b) The BMSCs viability with 6 min stimulation duration. (c) The BMSCs viability with 9 min stimulation duration.
The specified parameters of BPNN.
| Name | Input | Output | Maximum number of epochs | Learning rate | Accuracy |
|---|---|---|---|---|---|
| Number | 3 | 1 | 1000 | 0.1 | 0.0001 |
The specified parameters of GA.
| Name | Population size | Iteration | Mutation probability (PM) | Crossover probability (PC) |
|---|---|---|---|---|
| Number | 50 | 100 | 0.1 | 0.8 |
Figure 7The prediction results of the GA-BPNN.
Figure 8The verification experiments. (a) The control group. (b) The LIPUS-treated group under the optimized condition (6.92 V voltage, 1.02 MHz frequency, and 7.3 min stimulation duration) by GA-BPNN algorithm. n = 5 for each group; bar = 200 μm.
Figure 9The BMSCs viability with different methods. Data presented as mean ± SD. P < 0.01.
BMSCs viability (%) with different methods. Data presented as mean ± SD, n = 5. (P < 0.01).
| Control | LIPUS-treated | LIPUS-treated (GA-BPNN) | |
|---|---|---|---|
| BMSCs viability (%) | 100 | 119.57 ± 3.85 | 124.93 ± 1.28 |
| Confidence intervals (%) | [100,100] | [116.6,122.07] | [123.34,126.52] |
|
| — | 4.73 | 8.65 |